Despite Artery Concerns, FDA Approves Tasigna For Use By Children
The FDA has approved the use of the leukemia drug Tasigna for children, despite recent concerns that it could cause artery hardening and thickening.
The FDA has approved the use of the leukemia drug Tasigna for children, despite recent concerns that it could cause artery hardening and thickening.
A Tasigna lawsuit filed against Novartis claims that the cancer drug can cause arteries to constrict and harden, and that the company failed to warn U.S. doctors of the adverse…